Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA’s Crawford Backs Away From Forced Antihistamine Switch Controversy

Apr 05 2004

• By The Tan Sheet

Related Content

FDA Rx-To-OTC Switch Petition Refusal Would Not Result In WellPoint Suit

Oct 20 2003

Pfizer, Aventis Still See Wiggle Room On FDA-Mandated Switches

Aug 04 2003

Additional Topics

OTC Drugs Consumer

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window